Literature DB >> 2525176

The 1B (NS2), 1C (NS1) and N proteins of human respiratory syncytial virus (RSV) of antigenic subgroups A and B: sequence conservation and divergence within RSV genomic RNA.

P R Johnson1, P L Collins.   

Abstract

A 2330 nucleotide sequence spanning the 1B (NS2), IC (NS1) and N genes and intergenic regions of human respiratory syncytial virus strain 18537, representing antigenic subgroup B, was determined by sequencing cloned cDNAs of intracellular mRNAs. Comparison with the previously reported sequences for strain A2 of subgroup A showed that 1B, 1C and N were highly conserved at the nucleotide level (78, 78 and 86% identity, respectively) and at the amino acid level (92, 87 and 96% identity, respectively). The gene-start signals were exactly conserved between subgroups, and the gene-end signals contained only a single nucleotide substitution each in 1B and N. In most cases intergenic and non-coding gene sequences that were not part of presumed transcriptive signals were much less well conserved (generally 50 to 71%) than sequences that were part of translational open reading frames (82 to 86%). The nucleotide and deduced amino acid sequences of the N gene and protein of the Long strain of subgroup A were determined by sequencing cDNA clones of intracellular mRNA; the nucleotide sequence (representing all but the first 10 nucleotides of the gene) contained 15 differences from that of the A2 strain, but the deduced amino acid sequences were identical.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2525176     DOI: 10.1099/0022-1317-70-6-1539

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  24 in total

1.  Transcription of human respiratory syncytial virus genome RNA in vitro: requirement of cellular factor(s).

Authors:  S Barik
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

2.  Antigenic characterization of respiratory syncytial virus group A and B isolates in Rio de Janeiro, Brazil.

Authors:  M M Siqueira; J P Nascimento; L J Anderson
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

3.  Genetic variability among group A and group B respiratory syncytial viruses in a children's hospital.

Authors:  W B Coggins; E J Lefkowitz; W M Sullender
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

4.  The NS1 protein of human respiratory syncytial virus is a potent inhibitor of minigenome transcription and RNA replication.

Authors:  P L Atreya; M E Peeples; P L Collins
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

5.  Molecular characterization of an outbreak of respiratory syncytial virus (subgroup A) in Havana, Cuba, by monoclonal antibodies and restriction mapping (N gene).

Authors:  A Valdivia; D Chacón; C Savón; S Oropesa; L Sarmiento; O Valdes; A Otero; D Rosario; A Goyenechea
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

Review 6.  Respiratory syncytial virus genetic and antigenic diversity.

Authors:  W M Sullender
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

7.  Cytolytic T-lymphocyte responses to respiratory syncytial virus: effector cell phenotype and target proteins.

Authors:  J A Nicholas; K L Rubino; M E Levely; E G Adams; P L Collins
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

8.  Evolution of subgroup A respiratory syncytial virus: evidence for progressive accumulation of amino acid changes in the attachment protein.

Authors:  P A Cane; C R Pringle
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

9.  Effect of changes in the nucleotide sequence of the P gene of respiratory syncytial virus on the electrophoretic mobility of the P protein.

Authors:  C Caravokyri; C R Pringle
Journal:  Virus Genes       Date:  1992-01       Impact factor: 2.332

10.  High genetic diversity of the attachment (G) protein of human metapneumovirus.

Authors:  Nobuhisa Ishiguro; Takashi Ebihara; Rika Endo; Xiaoming Ma; Hideaki Kikuta; Hiroaki Ishiko; Kunihiko Kobayashi
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.